Photocontact Dermatitis Due to Piroxicam: Photopatch Testing.

Lymphomatoid photocontact dermatitis to benzydamine hydrochloride.

Topical dexketoprofen as a cause of photocontact dermatitis.

We reported on the case of a patient who developed a cutaneous eruption in a photoexposed area 1 week after a continous topical treatment with dexketoprofen (Enangel). Photopatch tests were positive for dexketoprofen, ketoprofen and piketoprofen and patch test was positive for piketoprofen. Control photopatch testing with dexketoprofen in 15 healthy volunteers was negative. Dexketoprofen, ketop...

[Fixed drug eruption due to piroxicam].

Piroxicam is a nonsteroidal antiinflammatory drug (NSAID) of the oxicam group and has anti-inflammatory, analgesic, antipyretic, and antiplatelet properties. It is a potent prostaglandin inhibitor with a long half-life in plasma (36-58 hours), meaning that it can be administered in a single daily dose. Multiple adverse systemic effects have been reported for piroxicam, of which the most common ...

Photopatch testing: a consensus methodology for Europe.

A group of interested European Contact Dermatologists/Photobiologists met to produce a consensus statement on methodology, test materials and interpretation of photopatch testing. While it is recognized that a range of local variables operate throughout Europe, the underlying purpose of the work is to act as an essential preamble to a Pan European Photopatch Test Study focusing particularly on ...

Action spectrum for etofenamate photoallergic contact dermatitis.

Topical photoallergic contact dermatitis (PACD) is investigated by photopatch testing, and a consensus European methodology exists, which advises the use of ultraviolet (UV)A as the irradiation source (1). However, for most agents, the action spectrum for PACD has not been defined. We sought to determine the action spectrum for topical photocontact allergy to the non-steroidal antiinflammatory ...